| Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors (NCT00020150) | National Cancer Institute (NCI) | 2000-06-01 |
| Phase II Study of a B7-1 Gene-Modified Autologous Tumor Cell Vaccine and Systemic IL-2 (NCT00031564) | H. Lee Moffitt Cancer Center and Research Institute | 2000-05-01 |
| Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and Metastases (NCT00006255) | Case Comprehensive Cancer Center | 2000-04-01 |
| Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer (NCT00004879) | Jonsson Comprehensive Cancer Center | 2000-04-01 |
| Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer (NCT00005045) | Eastern Cooperative Oncology Group | 2000-03-01 |
| Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients (NCT00579514) | Memorial Sloan Kettering Cancer Center | 2000-03-01 |
| Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma (NCT00004244) | National Cancer Institute (NCI) | 2000-03-01 |
| Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer) (NCT00019955) | National Cancer Institute (NCI) | 2000-03-01 |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer (NCT00005816) | Duke University | 2000-02-01 |
| Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients (NCT06531629) | Peking University First Hospital | 2000-01-01 |
| Optimization of Management for Sporadic Bilateral Renal Cell Carcinoma (NCT06369519) | Peking University First Hospital | 2000-01-01 |
| Arsenic Trioxide in Treating Patients With Metastatic Kidney Cancer (NCT00005069) | Memorial Sloan Kettering Cancer Center | 2000-01-01 |
| Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery (NCT00006126) | Northwestern University | 1999-09-01 |
| Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT00004095) | Northwestern University | 1999-08-01 |
| Dolastatin 10 in Treating Patients With Advanced Kidney Cancer (NCT00003914) | Mayo Clinic | 1999-08-01 |
| Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer (NCT00004065) | Memorial Sloan Kettering Cancer Center | 1999-07-01 |
| Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer (NCT00005038) | The Christie NHS Foundation Trust | 1999-06-01 |
| Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer (NCT00003968) | National Cancer Institute (NCI) | 1999-06-01 |
| Bryostatin 1 In Treating Patients With Progressive Kidney Cancer (NCT00005056) | Cancer Research UK | 1999-03-01 |
| Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer (NCT00004135) | University of Chicago | 1999-02-01 |
| Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer (NCT00003656) | Weill Medical College of Cornell University | 1999-01-01 |
| Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer (NCT00003928) | Case Comprehensive Cancer Center | 1999-01-01 |
| Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer (NCT00003102) | Ludwig Institute for Cancer Research | 1998-11-17 |
| Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors (NCT00003926) | Masonic Cancer Center, University of Minnesota | 1998-11-01 |
| Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically (NCT00003664) | Cancer Biotherapy Research Group | 1998-10-01 |
| Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research (NCT05539677) | N.N. Petrov National Medical Research Center of Oncology | 1998-09-01 |
| Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer (NCT00003551) | Emory University | 1998-08-01 |
| Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation (NCT00003887) | Fred Hutchinson Cancer Center | 1998-08-01 |
| Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer (NCT00003584) | University of New Mexico | 1998-07-01 |
| High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2 (NCT00080977) | Blumenthal Cancer Center at Carolinas Medical Center | 1998-06-01 |
| 6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer (NCT00003390) | Memorial Sloan Kettering Cancer Center | 1998-06-01 |
| Interferon Alfa in Treating Patients With Advanced Kidney Cancer (NCT00003542) | Memorial Sloan Kettering Cancer Center | 1998-05-01 |
| Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer (NCT00003408) | Cancer Treatment Centers of America | 1998-04-01 |
| Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease (NCT00026884) | National Cancer Institute (NCI) | 1998-03-12 |
| Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer (NCT00003683) | UNICANCER | 1998-03-01 |
| Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer (NCT00003553) | National Heart, Lung, and Blood Institute (NHLBI) | 1998-02-09 |
| Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer (NCT00053807) | European Organisation for Research and Treatment of Cancer - EORTC | 1998-02-01 |
| Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors (NCT00003107) | Indiana University | 1997-10-01 |
| Chemotherapy in Treating Patients With Solid Tumors (NCT00003103) | Memorial Sloan Kettering Cancer Center | 1997-08-01 |
| Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer (NCT00003126) | Loyola University | 1997-06-01 |
| Vaccine Therapy in Treating Patients With Advanced Kidney Cancer (NCT00004880) | Jonsson Comprehensive Cancer Center | 1997-06-01 |
| Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer (NCT00002947) | Yale University | 1996-10-01 |
| Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer (NCT00003585) | University of New Mexico | 1996-08-01 |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma (NCT00002764) | European Organisation for Research and Treatment of Cancer - EORTC | 1996-04-01 |
| Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer (NCT00002737) | European Organisation for Research and Treatment of Cancer - EORTC | 1996-03-01 |
| Biological Therapy in Treating Patients With Metastatic Cancer (NCT00002733) | Hoag Memorial Hospital Presbyterian | 1996-01-01 |
| Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors (NCT00002610) | Children's Oncology Group | 1996-01-01 |
| High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma (NCT00003091) | Hoag Memorial Hospital Presbyterian | 1996-01-01 |
| Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer (NCT00002846) | Blumenthal Cancer Center at Carolinas Medical Center | 1995-09-01 |
| Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer (NCT00002847) | Blumenthal Cancer Center at Carolinas Medical Center | 1995-09-01 |
| Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer (NCT00002611) | Children's Oncology Group | 1995-07-01 |
| Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma (NCT00002641) | European Organisation for Research and Treatment of Cancer - EORTC | 1995-02-01 |
| Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas (NCT00019019) | National Institutes of Health Clinical Center (CC) | 1994-10-01 |
| The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC) (NCT01447199) | M.D. Anderson Cancer Center | 1994-09-01 |
| Lymphocyte Therapy in Treating Patients With Kidney Cancer (NCT00002589) | National Cancer Institute (NCI) | 1994-07-01 |
| Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor (NCT00003804) | University of Leicester | 1993-07-01 |
| SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer (NCT00900042) | SWOG Cancer Research Network | 1993-07-01 |
| Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer (NCT00002515) | Memorial Sloan Kettering Cancer Center | 1992-10-01 |
| Kidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney Cancer (NCT00002473) | European Organisation for Research and Treatment of Cancer - EORTC | 1992-03-01 |
| Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer (NCT00002475) | St. Vincent Medical Center - Los Angeles | 1991-04-01 |
| Interleukin-2 in Treating Patients With Metastatic Kidney Cancer (NCT00018941) | National Cancer Institute (NCI) | 1991-04-01 |
| Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders (NCT00001238) | National Cancer Institute (NCI) | 1990-12-05 |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer (NCT00002466) | Memorial Sloan Kettering Cancer Center | 1990-05-01 |
| S0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney Cancer (NCT00311545) | SWOG Cancer Research Network | |
| Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer (NCT00416429) | Centre Leon Berard | |
| An Expanded Access Program to Axitinib is Available for Patients With Advanced Forms of Kidney Cancer (Ductal; Papillary; Chromophobic; Oncocytic) With Mutations in VHL, PBRM1 / BAP1, SETD2, VEGF) (NCT05941637) | Lynkcell Europe | |
| Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer (NCT00416871) | Centre Leon Berard | |
| SU006668 in Treating Patients With Advanced Solid Tumors (NCT00024063) | Jonsson Comprehensive Cancer Center | |